Analysis on the Beneficiary Population of Beijing TCM Dominant Diseases Treatment Costs Based on SHA 2011
- VernacularTitle:基于"SHA 2011"的北京市中医优势病种治疗费用受益人群分析
- Author:
Zixuan DAI
1
;
Liming LIU
;
Xiaowei MAN
;
Wei CHENG
Author Information
1. 北京中医药大学管理学院 北京 102488
- Keywords:
A System of Health Accounts 2011;
TCM dominant diseases;
treatment cost;
beneficiary population;
Beijing
- From:
Chinese Health Economics
2024;43(2):45-48
- CountryChina
- Language:Chinese
-
Abstract:
Objective:It analyzed the population aggregation characteristics of the treatment costs for Traditional Chinese Medi-cine(TCM)dominant diseases,and make targeted recommendations for relevant health policies.Methods:A total of 205 medical insti-tutions were obtained through stratified whole-cluster sampling to analyze the composition of the beneficiary population based on Sys-tem of Health Accounts 2011 for the treatment costs of TCM dominant diseases for local residents in Beijing in 2019.Results:The treatment costs of Beijing's TCM dominant diseases are dominated by diseases that include basic western medicine treatment,with male patients'costs accounting for a higher proportion than those of females,and the trend of younger patients in types of diseases treated by TCM and the costs have mainly flowed to females,with more than 50%of the treatment costs being consumed by patients aged 60 years old and above.Conclusion:It is needed to pay attention to male and child patients aged 0～14 years and their priority diseases,strengthen the construction of Chinese medicine geriatric health services,and adopt differentiated strategies for different groups of people so as to maximize the advantages of Chinese medicine.
